164 related articles for article (PubMed ID: 34171062)
21. Prevalence of Helicobacter pylori infection in patients with precancerous changes and gastric cancer.
Farinati F; Valiante F; Germanà B; Della Libera G; Baffa R; Rugge M; Plebani M; Vianello F; Di Mario F; Naccarato R
Eur J Cancer Prev; 1993 Jul; 2(4):321-6. PubMed ID: 8358284
[TBL] [Abstract][Full Text] [Related]
22. Cyclooxigenase-2 and osteopontin in gastric pre-neoplastic lesions in relation to H-pylori infection and grade of inflammation.
Benedetti I; Hoyos J; Barrios L
Rev Esp Patol; 2020; 53(2):79-87. PubMed ID: 32199598
[TBL] [Abstract][Full Text] [Related]
23. Cancer precursor lesions in intact stomach Helicobacter pylori gastritis and in resected stomach gastritis.
Giuliani A; Spada S; Corona M; Demoro M; Di Bari M; Ricciardulli T; Galati G; Caporale A; Tocchi A; Angelico F
J Exp Clin Cancer Res; 2003 Sep; 22(3):371-8. PubMed ID: 14582693
[TBL] [Abstract][Full Text] [Related]
24. Microbiota according to gastric topography in patients with low or high risk of gastric cancer in Nariño, Colombia.
Caguazango JC; Pazos ÁJ
Biomedica; 2019 Aug; 39(Supl. 2):157-171. PubMed ID: 31529842
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of Helicobacter pylori infection and gastric mucosal abnormalities in chronic pancreatitis.
Manes G; Dominguez-Muñoz JE; Hackelsberger A; Leodolter A; Rössner A; Malfertheiner P
Am J Gastroenterol; 1998 Jul; 93(7):1097-100. PubMed ID: 9672337
[TBL] [Abstract][Full Text] [Related]
26. Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy.
Konturek PC; Rembiasz K; Konturek SJ; Stachura J; Bielanski W; Galuschka K; Karcz D; Hahn EG
Dig Dis Sci; 2003 Jan; 48(1):36-46. PubMed ID: 12645788
[TBL] [Abstract][Full Text] [Related]
27. Is there any relationship between functional dyspepsia and chronic gastritis associated with Helicobacter pylori infection?
Kyzekové J; Arlt J; Arltová M
Hepatogastroenterology; 2001; 48(38):594-602. PubMed ID: 11379362
[TBL] [Abstract][Full Text] [Related]
28. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
29. Atrophic gastritis in young children and adolescents.
Ricuarte O; Gutierrez O; Cardona H; Kim JG; Graham DY; El-Zimaity HM
J Clin Pathol; 2005 Nov; 58(11):1189-93. PubMed ID: 16254110
[TBL] [Abstract][Full Text] [Related]
30. Gastric atrophy, metaplasia, and dysplasia: a clinical perspective.
Kapadia CR
J Clin Gastroenterol; 2003; 36(5 Suppl):S29-36; discussion S61-2. PubMed ID: 12702963
[TBL] [Abstract][Full Text] [Related]
31. [Gastric mucosa lesions in gastric ulcer disease. Initial study and 1-year follow-up after Helicobacter pylori eradication].
Bermejo F; Boixeda D; Gisbert JP; Sanz JM; Defarges V; Alvarez Calatayud G; Martín de Argila C
Gastroenterol Hepatol; 2000; 23(6):269-74. PubMed ID: 15324621
[TBL] [Abstract][Full Text] [Related]
32. Close correlation of intestinal metaplasia and corpus gastritis in patients infected with Helicobacter pylori.
Meining A; Stolte M
Z Gastroenterol; 2002 Aug; 40(8):557-60. PubMed ID: 12297978
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of Helicobacter pylori infection in advanced gastric carcinoma.
Araújo-Filho I; Brandão-Neto J; Pinheiro LA; Azevedo IM; Freire FH; Medeiros AC
Arq Gastroenterol; 2006; 43(4):288-92. PubMed ID: 17406757
[TBL] [Abstract][Full Text] [Related]
34. Update on the pathologic approach to the diagnosis of gastritis, gastric atrophy, and Helicobacter pylori and its sequelae.
Sipponen P
J Clin Gastroenterol; 2001 Mar; 32(3):196-202. PubMed ID: 11246343
[TBL] [Abstract][Full Text] [Related]
35. Childhood and Coress model of carcinogenesis.
Brigic E; Hadzic D; Mladina N
Med Arch; 2012; 66(6):375-7. PubMed ID: 23409514
[TBL] [Abstract][Full Text] [Related]
36. A five-year follow-up study on the pathological changes of gastric mucosa after H. pylori eradication.
Zhou L; Sung JJ; Lin S; Jin Z; Ding S; Huang X; Xia Z; Guo H; Liu J; Chao W
Chin Med J (Engl); 2003 Jan; 116(1):11-4. PubMed ID: 12667379
[TBL] [Abstract][Full Text] [Related]
37. Synergistic effect of IL-1β and TNF-α polymorphisms on the H. pylori-related gastric pre-malignant condition.
Tahara T; Shibata T; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Kamiya Y; Ishizuka T; Nakagawa Y; Nagasaka M; Iwata M; Nakamura M; Hirata I; Arisawa T
Hepatogastroenterology; 2012; 59(120):2416-20. PubMed ID: 23169178
[TBL] [Abstract][Full Text] [Related]
38. Ghrelin in diseases of the gastric mucosa associated with Helicobacter pylori infection.
Zub-Pokrowiecka A; Rembiasz K; Konturek SJ; Budzynski A; Konturek PC; Budzynski P
Med Sci Monit; 2010 Oct; 16(10):CR493-500. PubMed ID: 20885354
[TBL] [Abstract][Full Text] [Related]
39. Features of gastritis predisposing to gastric adenoma and early gastric cancer.
Meining A; Riedl B; Stolte M
J Clin Pathol; 2002 Oct; 55(10):770-3. PubMed ID: 12354805
[TBL] [Abstract][Full Text] [Related]
40. Association of Helicobacter pylori infection with atrophic gastritis and intestinal metaplasia.
Ohkuma K; Okada M; Murayama H; Seo M; Maeda K; Kanda M; Okabe N
J Gastroenterol Hepatol; 2000 Oct; 15(10):1105-12. PubMed ID: 11106088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
